Phase II study of zoledronic acid combined with docetaxel for non‐small‐cell lung cancer: W est J apan O ncology G roup-Reference-Cited by-同舟云学术

Phase II study of zoledronic acid combined with docetaxel for non‐small‐cell lung cancer: W est J apan O ncology G roup

Published:2014-07-12 Issue:8 Volume:105 Page:989-995
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Murakami Haruyasu¹,Yamanaka Takeharu²,Seto Takashi³,Sugio Kenji³⁴,Okamoto Isamu⁵⁶,Sawa Toshiyuki⁷,Hirashima Tomonori⁸,Takeda Koji⁹,Atagi Shinji¹⁰,Fukuoka Masahiro¹¹,Nakanishi Yoichi⁶¹²,Nakagawa Kazuhiko⁵,Yamamoto Nobuyuki¹¹³

Affiliation:

1. Division of Thoracic Oncology Shizuoka Cancer Center Shizuoka Japan

2. Department of Biostatistics National Cancer Center TokyoJapan

3. Department of Thoracic Oncology National Kyushu Cancer Center FukuokaJapan

4. Department of Thoracic and Breast Surgery Faculty of Medicine Oita University OitaJapan

5. Department of Medical Oncology Kinki University Faculty of Medicine OsakaJapan

6. Center for Clinical and Translational Research Kyusyu University Hospital FukuokaJapan

7. Division of Respiratory Medicine and Medical Oncology Gifu Municipal Hospital GifuJapan

8. Department of Thoracic Malignancy Osaka Prefectural Medical Center for Respiratory and Allergic Diseases OsakaJapan

9. Department of Clinical Oncology Osaka City General Hospital OsakaJapan

10. Department of Thoracic Oncology Kinki‐Chuo Chest Medical Center OsakaJapan

11. Department of Medical Oncology Izumi City Hospital OsakaJapan

12. Research Institute for Diseases of the Chest Graduate School of Medical Sciences Kyushu University FukuokaJapan

13. Third Department of Internal Medicine Wakayama Medical University Wakayama Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12448

Reference27 articles.

1. Cancer statistics, 2013

2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

3. American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

4. Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

5. Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone-modifying agents for non–small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review;Seminars in Oncology;2023-06

2. Synergistic effect of docetaxel and gambogic acid on bone metastasis of lung cancer;Bulletin du Cancer;2023-05

3. Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis;Journal of Bone Oncology;2023-04

4. Zoledronic acid enhances the efficacy of immunotherapy in non-small cell lung cancer;International Immunopharmacology;2022-09

5. Inhibition of metastatic bone cancer with a cascade targeting of docetaxel;Journal of Drug Delivery Science and Technology;2022-08